About Dylan Sammut

Dylan joined Irving Levin in October 2018 as a Research and Editorial Associate and is responsible for reporting on mergers and acquisitions in the healthcare sector. He graduated from Alfred University in May 2014 with a degree in English and Political Science. He currently lives in Bridgeport, CT with his fiancé and his overweight cat, Kimba, and in his free time he plays video games, reads, writes, and hikes on the weekends all year around.

Articles Written by Dylan Sammut

Takeda Divests Another Portfolio

Takeda Divests Another Portfolio

by | Apr 28, 2020 8:11 am | Pharmaceuticals

In another step to slim down its product line, Takeda Pharmaceuticals (NYSE: TAK) announced another portfolio divestment. Orifarm Group A/S, an ambitious operator in the European pharmaceutical market, has purchased Takeda’s portfolio of select non-core... Read More »
Novartis Enters the Game With Ubisoft

Novartis Enters the Game With Ubisoft

by | Apr 28, 2020 8:07 am | eHealth

Last week, an unusual partnership in the health care M&A space hit the headlines. Novartis AG (NYSE: NVS), the global pharmaceutical company, bought Amblyotech, Inc., a software startup that, in collaboration with Ubisoft (OTCMKTS: UBSFF) and McGill University, is... Read More »